An investigation on behalf of investors in Immunovant, Inc. (NASDAQ:IMVT) shares over potential wrongdoing at Immunovant, Inc. was announced and NASDAQ:IMVT stockholders should contact the Shareholders Foundation.
San Diego, CA -- (SBWIRE) -- 08/17/2020 -- An investigation on behalf of investors in shares of Immunovant, Inc. (NASDAQ: IMVT) was announced over potential breaches of fiduciary duties by certain officers and directors at Immunovant, Inc. .
Investors who purchased shares of Immunovant, Inc. (NASDAQ: IMVT) have certain options and should contact the Shareholders Foundation at email@example.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain Immunovant, Inc. directors breached their fiduciary duties and caused damage to the company and its shareholders.
New York based Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. On April 14, 2020, Immunovant, Inc. (NASDAQ: IMVT) announced the pricing of its underwritten public offering of 8,359,448 shares of its common stock at a price to the public of $14.50 per share. Immunovant, Inc estimated the the aggregate gross proceeds to Immunovant its initial public offering to be approximately $121.2 million, before deducting underwriting discounts and commissions and offering expenses.
Since then shares of Immunovant, Inc. (NASDAQ: IMVT) increased to as high as $29.96 per share on June 25, 2020.
Those who purchased shares of Immunovant, Inc. (NASDAQ: IMVT), have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North - Suite 423
92108 San Diego
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.